The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages

  1. Hiromi Iwasaki1,2,
  2. Shin-ichi Mizuno2,
  3. Yojiro Arinobu2,
  4. Hidetoshi Ozawa2,
  5. Yasuo Mori1,
  6. Hirokazu Shigematsu2,
  7. Kiyoshi Takatsu3,
  8. Daniel G. Tenen4, and
  9. Koichi Akashi1,2,5
  1. 1Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka 812-8582, Japan;
  2. 2Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA;
  3. 3Division of Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan;
  4. 4Harvard Institutes of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA

    Abstract

    The mechanism of lineage specification in multipotent stem cells has not been fully understood. We recently isolated progenitors with the eosinophil, basophil, or mast cell lineage potential, all of which originate from granulocyte/monocyte progenitors (GMPs). By using these prospectively purified progenitors, we show here that the expression timing of GATA-2 and CCAAT enhancer-binding protein α (C/EBPα) can differentially control their lineage commitment. The expression of GATA-2 instructed C/EBPα-expressing GMPs to commit exclusively into the eosinophil lineage, while it induced basophil and/or mast cell lineage commitment if C/EBPα was suppressed at the GMP stage. Furthermore, simply by switching the order of C/EBPα and GATA-2 transduction, even lymphoid-committed progenitors recaptured these developmental processes to be reprogrammed into each of these lineages. We propose that the order of expression of key transcription factors is critical for their interplay to selectively drive lineage specification programs, by which stem cells could generate multiple lineage cells in a hierarchical manner.

    Keywords

    Footnotes

    | Table of Contents

    Life Science Alliance